International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-5 doi: 10.5281/zenodo.8358711
Original Article
Assessment of Safety and Utility of Image Guided Percutaneous Biopsy in Intrathoracic Lesions
 ,
 ,
 ,
 ,
Published
Sept. 19, 2023
Abstract

Intrathoracic lesions, encompassing pulmonary, pleural, and mediastinal masses, necessitate histopathological assessment for precise diagnosis. Image-guided percutaneous biopsy has emerged as a technique to attain this. This study evaluates its utility, reasons for inconclusive results, and associated complications.

Methods: 120 patients, who had prior imaging indicating an intrathoracic lesion, were enrolled post-ethical committee clearance and obtaining informed consent. The biopsy was conducted using Siemens 128 slice CT scanner or GE 16 slice CT scanner. Feasibility for image-guided biopsy was determined and procedures were executed. A follow-up evaluation comprised:

a) Histopathology outcomes.

b) Reasons for inconclusive results.

c) Complications, their management, and effect on the patient's clinical outcome.

Results: Conclusive histopathological results were received in 89.1% of cases, aligning with existing literature standards. The findings were significantly valuable for the attending physician. Factors leading to inconclusive results included small lesion size, intraprocedural complications, necrotic core biopsies, and the need for additional samples for IHC examination. Complications, primarily pneumothorax and hemorrhage, were observed in 22% of participants. This rate is consistent with prevailing literature. Most complications were conservatively managed, with only 4.1% requiring further intervention. Monitoring the patients' clinical status revealed symptomatic improvements, affirming the safety and reliability of the biopsy method for intrathoracic lesions.

Conclusion: Image-guided percutaneous biopsy of intrathoracic lesions stands as a safe and dependable technique, offering low complication rates and significant diagnostic insight into pulmonary, pleural, and mediastinal masses

Recommended Articles
Loading Image...
Volume-4, Issue-5
Citations
1588 Views
335 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved